Myocardial Ischemia: A Silent Epidemic in Type 2 Diabetes Patients

• Wild S , RoglicG, GreenA, SicreeR, KingH: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diabetes Care, 27, 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Cowie CC , RustKF, FordESet al.: Full accounting of diabetes and prediabetes in the US population in 1988–1994 and 2005–2006.Diabetes Care, 32, 287–294 (2009).
   PubMed Web of Science ®Google Scholar
• Narayan KM , BoyleJP, GeissLS, SaaddineJB, ThompsonTJ: Impact of recent increase in incidence on future diabetes burden: US, 2005–2050.Diabetes Care, 29, 2114–2116 (2006).
   PubMed Web of Science ®Google Scholar
• Cohn PF : Should silent ischemia be treated in asymptomatic individuals?Circulation, 82(Suppl. II), 149–154 (1990).
   Web of Science ®Google Scholar
• Puel J , ValensiP, VanzettoGet al.: Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.Diabetes Metab., 30(3 Pt 3), S3–S18 (2004).
   Web of Science ®Google Scholar
• American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February (1998), Miami, Florida. Diabetes Care, 21, 1551–1559 (1998).
   PubMedGoogle Scholar
• Diamond GA , KaulS, ShahPK: Screen testing cardiovascular prevention in asymptomatic diabetic patients.J. Am. Coll. Cardiol., 1549, 1915–1917 (2007).
   Google Scholar
• Hiebel A , Fagot-CampagnaA, FosseS, Varroud-VidalM, WeillA, PenfornisA: Feasibility of screening for silent myocardial ischemia according to the ALFEDIAM-SFC 2004 guidelines in a population of diabetic patients.Diabetes Metab., 36, 286–292 (2010).
   PubMed Web of Science ®Google Scholar
• Shirani J , DilsizianV: Screening asymptomatic patients with Type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?Curr. Cardiol. Rep., 12, 140–146 (2010).
   PubMedGoogle Scholar
• The BARI 2D study group: A randomized trial of therapies for Type 2 diabetes and coronary artery disease. N. Engl. J. Med., 360, 2503–2515 (2009).
   PubMed Web of Science ®Google Scholar
• Henderson RA , PocockSJ, ClaytonTCet al.: Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.J. Am. Coll. Cardiol., 142, 1161–1170 (2003).
   Google Scholar
• Hueb W , LopesNH, GershBJet al.: Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.Circulation, 115, 1082–1089 (2007).
   PubMed Web of Science ®Google Scholar
• Boden WE , O‘RourkeRA, TeoKKet al.: COURAGE Trial Research Group: optimal medical therapy with or without PCI for stable coronary disease.N. Engl. J. Med., 356, 1503–1516 (2007).
   PubMed Web of Science ®Google Scholar
• Hakeem A , BhattiS, KarmaliKNet al.: Renal function and risk stratification of diabetic and non diabetic patients undergoing evaluation for coronary artery disease.JACC Cardiovasc. Imaging, 7, 734–745 (2010).
   Google Scholar
• Kamalesh M , ShenJ: Diabetes and peripheral arterial disease in men: trends in prevalence, mortality, and effect of concomitant coronary disease.Clin. Cardiol., 32, 442–446 (2009).
   PubMed Web of Science ®Google Scholar
• Grundy SM , BenjaminIJ, BurkeGLet al.: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.Circulation, 100, 1134–1146 (1999).
   PubMed Web of Science ®Google Scholar
• The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J. Am. Coll. Cardiol., 35(5), 1122–1129 (2000).
   PubMed Web of Science ®Google Scholar
• Koïstinen MJ : Prevalence of asymptomatic myocardial ischemia in diabetic subjects.Br. Med. J., 301, 92–95 (1990).
   PubMed Web of Science ®Google Scholar
• Milan Study on Atherosclerosis and Diabetes (MiSAD) group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am. J. Cardiol., 79, 134–139 (1997).
   PubMed Web of Science ®Google Scholar
• Vanzetto G , HalimiS, HammoudTet al.: Prediction of cardio-vascular events in clinically selected high-risk NIDDM patients.Diabetes Care, 22, 19–26 (1999).
   PubMedGoogle Scholar
• Valensi P , PariesJ, Brulport-CerisierVet al.: Predictive value of silent myocardial ischemia for cadiac events in diabetic patients: influence of age in a French multicenter study.Diabetes Care, 11, 2722–2727 (2005).
   Google Scholar
• Kip KE , FaxonDP, DetreKMet al.; The NHLBI Registry. Coronary angioplasty in diabetic patients. The National Heart, Lung and Blood Institute percutaneous transluminal coronary angioplasty registry. Circulation, 94, 1818–1825 (1996).
   PubMed Web of Science ®Google Scholar
• Gaede P , Lund-AndersenH, ParvingHH, PedersenO: Effect of a multifactorial intervention on mortality in Type 2 diabetes.N. Engl. J. Med., 358, 580–591 (2008).
   PubMed Web of Science ®Google Scholar
• Rogers WJ , BourassaMG, AndrewsTCet al.: Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.J. Am. Coll. Cardiol. (3), 594–605 (1995).
   PubMed Web of Science ®Google Scholar
• Fox KM : European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators: efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicenter trial (the EUROPA study).Lancet, 362(9386), 782–788 (2003).
   PubMed Web of Science ®Google Scholar
• Yusuf S , ZuckerD, PeduzziPet al.: Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.Lancet, 344(8922), 563–570 (1994). Erratum in: Lancet, 344(8934), 1446 (1994).
   PubMed Web of Science ®Google Scholar
• Morice MC , SerruysPW, KappeteinAPet al.: Outcomes in patients with de novo left main disease treated with either PCI using paclitaxel-eluting stents or CABG treatment in the SYNTAX trial.Circulation, 24, 2645–2653 (2010).
   Google Scholar
• Ferro A , PellegrinoT, SpinelliL, AcampaW, PetrettaM, CuocoloA: Comparison between dobutamine echocardiography and SPECT for interpretive reproductibility.Am. J. Cardiol., 100, 1239–1244 (2007).
   PubMed Web of Science ®Google Scholar
• Acampa W , SpinelliL, PetrettaM, De Lauro F, Ibello F, Cuocolo A: Prognostic value of myocardial ischemia in patients with uncomplicated AMI: direct comparison of stress echocardiography and myocardial perfusion imaging. J. Nucl. Med., 46, 417–423 (2005).
   PubMed Web of Science ®Google Scholar
• Le Feuvre C , BarthélémyO, Dubois-LaforgueDet al.: Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with Type 2 diabetes.Diabetes Metab., 31, 135–142 (2005).
   PubMed Web of Science ®Google Scholar
• Jacqueminet S , BarthelemyO, Le Feuvre C: Screening of silent myocardial ischemia in Type 2 diabetic patients. Diabetes Care, 33, 79 (2010).
   Google Scholar
• Barthelemy O , JacqueminetS, RouzetFet al.: Intensive care of cardiovascular risk factors and prevalence of silent myocardial ischemia in Type 2 diabetic patients.Arch. Cardiovasc. Dis., 101, 539–547 (2008).
   PubMed Web of Science ®Google Scholar
• Young LH , WackersFJ, ChyunDAet al.: Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with Type 2 diabetes. The DIAD study: a randomized controlled trial.JAMA, 301, 1547–1555 (2009).
   PubMed Web of Science ®Google Scholar
• Valensi P , SachsRN, LormeauBet al.: Silent myocardial ischemia and left ventricle hypertrophy in diabetic patients.Diabetes Metab., 23, 409–416 (1997).
   PubMed Web of Science ®Google Scholar
• Jannand-Delenne B , SavinB, HabibG, BoryM, VagueP, Lassmann-VagueV: Silent myocardial ischemia in patients with diabetes.Diabetes Care, 22, 1396–1400 (1999).
   PubMedGoogle Scholar
• Nitenberg A , ValensiP, SachsR, DaliM, AptecarE, AttaliJR: Impairment of coronary vascular reserve and Ach-induced coronary vasodialtion in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.Diabetes, 42, 1017–1025 (1993).
   PubMed Web of Science ®Google Scholar
• Conroy RM , PiöräläK, FitzgeraldAPet al.: Estimation of ten-years risk of fatal cardiovascular disease in Europe: the SCORE Project.Eur. Heart J., 24, 897–1003 (2003).
   PubMed Web of Science ®Google Scholar
• Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA, 285, 2487–2497 (2001).
   Web of Science ®Google Scholar
• Chobanian AV , BakrisGL, BlackHRet al.: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA, 289(19), 2560–2572 (2003) Erratum in: JAMA, 290(2), 197 (2003).
   PubMed Web of Science ®Google Scholar
• Schouten O et al. , van Kuijk JP, Flu WJ : Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery. Am. J. Cardiol., 103, 897–901 (2009).
   PubMed Web of Science ®Google Scholar
• Faglia E , ManuelaM, AntonellaQet al.: Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with Type 2 diabets mellitus at high cardiovascular risk: an open-label randomized pilot study.Am. Heart J., 149, e1–e6 (2005).
   PubMed Web of Science ®Google Scholar

Website

• Medical treatment in Type 2 diabetic patients. Professional recommendations. HAS (2006) www.has-sante.fr
   Google Scholar